ALFA Finder
16:12 IST
BSE
Financial Results
Bacil Pharma Q2 FY27 Results: Net Loss of ₹0.1 Cr
Bacil Pharma Ltd reported a net loss of ₹0.1 Cr for Q2 FY27.
- Key figure
- Net loss ₹0.1 Cr
Bacil Pharma Ltd
- Share price
- ₹16.95
- Market cap
- ₹24.33 Cr
- Revenue (annual)
- ₹0.00 Cr
- Net profit (annual)
- ₹1.56 Cr
- P/E (TTM)
- 38.5×Sector 43.8×
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Other Announcement 6Board Meeting Date 6Financial Results 5Fund Raise 3Merger & Restructuring 2Management Change 2Board Meeting Outcome 2Partnership 1Capital Structure Change 1Annual Report 1Annual General Meeting 1
Time
5 announcements with these filters
16:14 IST
BSE
Financial Results
Bacil Pharma Q1 FY27 Results: Net Profit ₹0.3 Cr, Down 57.1% YoY
Bacil Pharma Ltd reported net profit of ₹0.3 Cr (-57.1% YoY) for Q1 FY27.
- Key figure
- Net profit ₹0.3 Cr · -57.1% YoY
20:45 IST
BSE
Financial Results
Bacil Pharma Q4 FY26 Results: Net Profit ₹0.6 Cr, Up 50.0% YoY
Bacil Pharma Ltd reported net profit of ₹0.6 Cr (+50.0% YoY) for Q4 FY26.
- Key figure
- Net profit ₹0.6 Cr · +50.0% YoY
20:44 IST
BSE
Financial Results
Bacil Pharma Financial Results
Bacil Pharma Limited reported audited financial results for the year ended March 2026. The board approved results showing a profit of ₹155.55 Lakhs from ordinary activities.
14:06 IST
BSE
Financial Results
Bacil Pharma Q3 FY26 Results: Net Profit ₹0 Cr
Bacil Pharma Ltd reported net profit of ₹0 Cr for Q3 FY26.
- Key figure
- Net profit ₹0 Cr